Key Highlights
- CrowdStrike expanded its share repurchase authorization by $500M, pushing total buyback capacity to $1.5 billion.
- CRWD shares began Monday’s session at $399.12 with a market capitalization near $101.2 billion.
- Morgan Stanley elevated CRWD to Overweight with a $510 price objective; consensus analyst target reaches ~$505.
- Institutional ownership stands at 71.16%; company insiders offloaded approximately 68,636 shares totaling $28.7M over three months.
- Fourth quarter revenue reached $1.31B, representing 23.8% year-over-year growth and surpassing projections by ~$10M.
CrowdStrike (CRWD) kicked off the week at $399.12, marking a substantial decline from its 52-week peak of $566.90.
CrowdStrike Holdings, Inc., CRWD
The cybersecurity leader revealed Monday that it’s boosting its stock repurchase initiative by an additional $500 million, elevating the complete authorization to $1.5 billion. Through the current program, the firm has already repurchased 413,130 Class A common shares at a weighted average cost of $364.57 per share, representing a cumulative expenditure of $150.6 million.
CFO Burt Podbere connected the expansion to the firm’s ambitious goal of achieving $20 billion in annual recurring revenue by fiscal 2036. “We have increased our share repurchase authorization to $1.5 billion to opportunistically return value to shareholders,” Podbere stated.
The buyback expansion arrives as CRWD shares hover approximately 30% beneath their annual peak, a decline partially attributed to broader sector pressure following speculation that emerging AI technologies might disrupt traditional security offerings.
Technical indicators show the stock’s 50-day moving average positioned at $411.92, with the 200-day moving average resting at $467.32 — both levels exceed current trading prices.
Wall Street Maintains Favorable Outlook
Analyst sentiment continues to skew positive overall. Morgan Stanley elevated CRWD from equal weight to overweight this March, simultaneously lifting its price objective from $487 to $510. Truist maintains a buy recommendation with a $550 target, while Daiwa carries an outperform designation with a $500 projection. The consensus price target among analysts hovers around $504.98, with an overall “Moderate Buy” rating based on input from 51 analysts.
The breakdown includes one strong buy recommendation, 34 buy ratings, 15 hold positions, and a single sell rating.
Runnymede Capital Advisors initiated a fresh stake during Q4, acquiring 3,160 shares valued at approximately $1.48 million. Multiple institutional investors have similarly increased their holdings in recent reporting periods, including Carnegie Investment Counsel and Traynor Capital Management.
Zacks Research revised CRWD from strong sell to hold this March, coinciding with the company’s fourth quarter performance that exceeded earnings projections — delivering $1.12 EPS compared to the $1.10 consensus, alongside revenue of $1.31 billion versus anticipated $1.30 billion.
Executive Share Dispositions Persist
Conversely, insider transactions have trended toward selling. CEO George Kurtz divested 28,853 shares in early February at an average price of $413.01, generating approximately $11.9 million in proceeds. This transaction trimmed his stake by 1.38%, leaving him with roughly 2.05 million shares remaining.
President Michael Sentonas disposed of 19,367 shares in late March at $411.06 per share, collecting about $7.96 million. Collectively, company insiders have sold around 68,636 shares valued at $28.7 million throughout the preceding 90-day period. Insider ownership currently represents approximately 3.32% of outstanding shares.
CrowdStrike has also recently enhanced its GovCloud platform and introduced a CTEM service in partnership with HCLTech, initiatives designed to expand penetration among enterprise clients and government agencies.
The security software provider’s 52-week trading range spans from a low of $298.00 to a high of $566.90. Wall Street analysts project EPS of $0.55 for the ongoing fiscal year.





